arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

ARTIVION, INC.

AORT
$27.16 ▲ +0.61 (+2.30%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
67 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
43
Health
Weak
Neutral
auto_awesome

Analytical Summary

ARTIVION, INC. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.3B
Dividend Yield
Revenue Growth 17.5%
Op. Margin 5.0%
ROIC 3.6%
FCF / Share $-0.14
Trailing P/E 905.3x
Price / Book 2.9x
FCF Yield
Debt / Equity 0.48
info Valuation on last close. End-of-day price, Aug 7, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$116.34M
↑ +17.5%
Net Income Profit after all expenses
$1.42M
↓ -41.6%
Operating Margin Operating profit as % of sales
5.0%
↓ -46.0% 51th
FCF / Share Free cash flow per share
$-0.14
↑ +70.8%
Long-Term Debt Long-term obligations
$215.35M
— +0.1%

Health Breakdown

Profitability
39
Returns
48
Financial Health
52
Cash Quality
25

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 67 quarters